New Chinese drug shows record treatment success against uncommon lung cancer
A new Chinese drug has shown record treatment success against an uncommon lung cancer, offering a beacon of hope for patients grappling with the disease, state media reported Monday.
The Phase 2 clinical trial of sunvozertinib, which aims to combat …